Share the post "Delivery Share Breakouts : Zydus Lifesciences and Others: 22-Jul-2024"
| Company Name | Initial Breakout Date | Initial Delivery Value | Final Breakout Date | Final Delivery Value | Delivery (In %) | Breakout | Current Price | High Price(52 W) | Low price (52 W) | Marketcap |
|---|---|---|---|---|---|---|---|---|---|---|
| Bengal Tea & Fabrics | Oct 16, 2023 | 4,300.69K | 22-Jul-2024 | 7,154.07K | 97.65% | 1 Year | Rs165 | Rs184 | Rs75.35 | 148.60 Cr |
| Zydus Lifesciences | Sep 28, 2023 | 2,568,253.18K | 22-Jul-2024 | 6,056,722.37K | 80.55% | 5 Years | Rs1154.4 | Rs1203.2 | Rs564.05 | 116,159.65 Cr |
Bengal Tea & Fabrics demonstrated diverse delivery trends during the 1 Year breakout period. Starting at 4,300.69K units on Oct 16, 2023, the delivery volume escalated to 7,154.07K units by 22-Jul-2024, marking a delivery rate of 97.65%. Throughout this breakout, the stock’s price fluctuated between a low of Rs161.25 and a high of Rs172.9, with the current price resting at Rs165. The company’s market capitalization is currently valued at 148.60 crores.
Zydus Lifesciences demonstrated diverse delivery trends during the 5 Years breakout period. Starting at 2,568,253.18K units on Sep 28, 2023, the delivery volume escalated to 6,056,722.37K units by 22-Jul-2024, marking a delivery rate of 80.55%. Throughout this breakout, the stock’s price fluctuated between a low of Rs1122 and a high of Rs1165.45, with the current price resting at Rs1154.4. The company’s market capitalization is currently valued at 116,159.65 crores.
Zydus Lifesciences Limited
62,075.00
Net Sales
14,825.00
Net Profit
62,707.00
Total Income
43,710.00
Expenditure
1,100
Current Price
1,10,686
Market Cap
In the most recent financial analysis for Zydus Lifesciences Limited, key metrics demonstrate a solid performance. The net sales reached ₹62,075.00 million, with total income amounting to ₹62,707.00 million. Expenditure was recorded at ₹43,710.00 million, resulting in a net profit of ₹14,825.00 million. EPS figures for continuing operations are ₹14.11. Other notable figures include other income of ₹632.00 million, finance costs of ₹322.00 million, and employee benefit expenses totaling ₹8,835.00 million. Depreciation and amortization expenses were ₹2,153.00 million, with current tax at ₹6,538.00 million and deferred tax at ₹-2,177.00 million. The total comprehensive income for the period was ₹14,589.00 million, and other comprehensive income net of taxes was ₹-236.00 million.
With a market capitalization of ₹1,10,686 crore, the company’s stock is currently priced at ₹1,100. The historical trading range of the stock is ₹1,324 / 568. The P/E ratio is remarkably high at 26.6, suggesting a significant valuation. The book value stands at ₹197, and the dividend yield is 0.27%. The Return on Capital Employed (ROCE) is 22.3%, and the Return on Equity (ROE) is 20.7%. The debt-to-equity ratio is very low at 0.04, though the company shows a negative net cash flow of ₹-74.8 crore. The Piotroski score is 8.00, with the Graham Number pegged at ₹429. The Price-to-Book (P/B) ratio of 5.58 highlights a premium valuation.
